These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 7348180)

  • 21. [Our method and concept concerning the activated clotting time (ACT) during cardiopulmonary bypass].
    Watanabe T; Abe T; Iyomasa Y
    Kokyu To Junkan; 1983 Jul; 31(7):781-6. PubMed ID: 6658213
    [No Abstract]   [Full Text] [Related]  

  • 22. Heparin rebound in open heart surgery.
    Gollub S
    Surg Gynecol Obstet; 1967 Feb; 124(2):337-46. PubMed ID: 6016829
    [No Abstract]   [Full Text] [Related]  

  • 23. [The role of the activated coagulation time (ACT) in open heart surgery--comparison between children and adult patients].
    Ohmi M; Tsuboi H; Furukawa S; Mohri H; Seo K
    Kyobu Geka; 1984 Nov; 37(12):945-8. PubMed ID: 6521115
    [No Abstract]   [Full Text] [Related]  

  • 24. [Control of blood coagulation in extracorporeal circulation].
    Neef H
    Med Klin; 1971 Jan; 66(1):16-21. PubMed ID: 5545364
    [No Abstract]   [Full Text] [Related]  

  • 25. [Activated coagulation time during extracorporeal circulation: useful for reducing the use of homologous blood?].
    Brandi LS; Benedetti M; Russo V; Grana M; Mosca F
    Minerva Anestesiol; 1984 Apr; 50(4):127-32. PubMed ID: 6472644
    [No Abstract]   [Full Text] [Related]  

  • 26. [Coagulation studies in extracorporeal circulation--with special reference to blood coagulation during placing of prosthetic heart valves].
    Kaku N
    Igaku Kenkyu; 1971 Sep; 41(6):471-84. PubMed ID: 5168960
    [No Abstract]   [Full Text] [Related]  

  • 27. [Blood coagulation problems during long-term extracorporeal circulation].
    Agostoni A; Uziel L; Cugno MM; Cacciabue E
    Ann Ital Med Int; 1986 Sep; 1(3):212-20. PubMed ID: 3275187
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experiences with Calciparin, a new subcutaneously injectable heparin preparation].
    Sessner HH; Brockhaus W; Kunzmann G; Stingl J
    Med Welt; 1971 Jan; 5():187-91. PubMed ID: 5546024
    [No Abstract]   [Full Text] [Related]  

  • 29. [Biologic modifications in the course of extracorporeal circulation].
    Cornu P; Mathey J; Hazan E JAUREGUIBERRY C
    Nouv Rev Fr Hematol; 1968; 8(1):92-8. PubMed ID: 4232156
    [No Abstract]   [Full Text] [Related]  

  • 30. ["Anti-hemophilic globulin" for relief of coagulation disorders after extracorporeal circulation].
    Wolff G; Grädel E; Rist M; Duckert F
    Thoraxchir Vask Chir; 1970 Dec; 18(6):489-96. PubMed ID: 5275548
    [No Abstract]   [Full Text] [Related]  

  • 31. [Premises to the study of blood coagulation changes in the course of extracorporeal circulation].
    Respighi E; Marcazzan E; Panzeri E
    Arch Chir Torac Cardiovasc; 1968; 25(3):207-27. PubMed ID: 4910329
    [No Abstract]   [Full Text] [Related]  

  • 32. [Plasma heparin levels during extracorporeal circulation and their significance].
    Taniguchi K; Ujihara Y; Miyamoto M; Miyako M; Hayano Y; Noguchi T; Honda N; Hadama T; Shirabe J
    Masui; 1986 Apr; 35(4):616-22. PubMed ID: 3747107
    [No Abstract]   [Full Text] [Related]  

  • 33. [Blood coagulation problems in long-term extracorporeal assistance for acute respiratory insufficiency].
    Agostoni A; Uziel L
    Recenti Prog Med; 1983 Aug; 74(8):910-22. PubMed ID: 6647986
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemorrhages during cardiac surgery with extracorporeal circulation].
    Gascon P; Daussy M; Daumet P
    Ann Chir Thorac Cardiovasc; 1967 Jul; 6(3):323-7. PubMed ID: 5618385
    [No Abstract]   [Full Text] [Related]  

  • 36. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of filters in extracorporeal circulation. Correlation with coagulation defects and neurological damage].
    Ferrozzi G; Sala A; Arena V; Biglioli P; Giuffrida G; Ferrozzi L
    Minerva Cardioangiol; 1977 Apr; 25(4):269-73. PubMed ID: 887204
    [No Abstract]   [Full Text] [Related]  

  • 38. [Blood coagulation disorders in extracorporeal circulation and clinical study on preventive countermeasures].
    Ban T
    Nihon Geka Hokan; 1966 Jul; 35(4):617-42. PubMed ID: 6008787
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in coagulation and platelet function during prolonged extracorporeal circulation (ECC) in sheep and man.
    Fong SW; Burns NE; Williams G; Woldanski C; Gazzaniga AB; Bartlett RH
    Trans Am Soc Artif Intern Organs; 1974; 20A():239-47. PubMed ID: 4450343
    [No Abstract]   [Full Text] [Related]  

  • 40. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols.
    Bull BS; Korpman RA; Huse WM; Briggs BD
    J Thorac Cardiovasc Surg; 1975 May; 69(5):674-84. PubMed ID: 1127966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.